Crosstalk between Heart Failure and Cognitive Impairment via hsa-miR-933/RELB/CCL21 Pathway

Wenxiao Feng1,2, Jie Yang3, Wenchao Song4

  • 1First Clinical Medical College, Shandong University of Traditional Chinese Medicine, Shandong, China.

Insights

This study explored the link between heart failure (HF) and cognitive impairment using bioinformatics. It identified a potential hsa-miR-933/RELB/CCL21 pathway involved in both conditions.

Area of Science:

  • Biomedical Informatics
  • Molecular Biology
  • Cardiology

Background:

  • Growing interest in the association between heart failure (HF) and cognitive impairment.
  • Lack of systematic studies on the role of microRNAs (miRNAs) in the crosstalk between HF and cognitive impairment.

Purpose of the Study:

  • To investigate the molecular mechanisms underlying the crosstalk between HF and cognitive impairment.
  • To identify potential biomarkers for cognitive impairment prediction in HF patients.

Main Methods:

  • Downloaded RNA-seq and clinical data from the Gene Expression Omnibus (GEO) database.
  • Utilized R software for statistical analysis to identify differentially expressed miRNAs (DE-miRNAs) and mRNAs (DE-mRNAs).
  • Constructed protein-protein interaction (PPI) networks and developed a logistic regression model for cognitive impairment prediction.

Main Results:

  • Identified DE-miRNAs and DE-mRNAs common to both HF and cognitive impairment.
  • Validated a logistic regression model based on DE-miRNAs for effective cognitive impairment prediction.
  • Established a core miRNA-transcription factor (TF)-mRNA regulatory pathway, highlighting hsa-miR-933/RELB/CCL21 as a key axis.

Conclusions:

  • This study represents the first bioinformatics approach to elucidate the crosstalk between HF and cognitive impairment.
  • The findings suggest a significant regulatory role of the hsa-miR-933/RELB/CCL21 axis in HF and cognitive impairment.
  • The identified pathway offers potential therapeutic targets for neurological disorders associated with HF.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
104
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.0K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
576
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
91
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
157
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
52